SCHEMBL30824281

CC[C@H](C)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)O)C(C)C)[C@@H](C)CC)C(C)C

nearest known ligand 0.70

Predicted protein targets (top 8)

	gene	UniProt	supporting neighbours	confidence
▸	NPY2R	P49146	8/20	0.70

▸	NPY4R	P50391	8/20	0.70

▸	NPY5R	Q15761	8/20	0.70

▸	NPY1R	P25929	6/20	0.70

▸	CXCR4	P61073	5/20	0.69

▸	CALCA	P06881	2/20	0.62

▸	RXFP1	Q9HBX9	1/20	0.62

▸	GLP1R	P43220	3/20	0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL30436894	0.92	CXCR4 (0.69)	NPY2RNPY4RNPY5RNPY1RCXCR4
SCHEMBL30658277	0.90	NPY2R (0.75)	NPY2RNPY4RNPY5RNPY1RCXCR4
SCHEMBL9073974	0.90	CXCR4 (0.72)	NPY2RNPY4RNPY5RNPY1RCXCR4
SCHEMBL31182815	0.90	NPY2R (0.73)	NPY2RNPY4RNPY5RNPY1RCXCR4
SCHEMBL30176426	0.90	NPY1R (0.69)	NPY2RNPY4RNPY5RNPY1RCXCR4
SCHEMBL30658215	0.90	NPY1R (0.72)	NPY2RNPY4RNPY5RNPY1RCXCR4
SCHEMBL30658324	0.89	NPY2R (0.71)	NPY2RNPY4RNPY5RNPY1RCXCR4
SCHEMBL29949636	0.89	NPY1R (0.71)	NPY2RNPY4RNPY5RNPY1RCXCR4
SCHEMBL30906468	0.89	NPY2R (0.68)	NPY2RNPY4RNPY5RNPY1RCXCR4
SCHEMBL30658318	0.89	CXCR4 (0.68)	NPY2RNPY4RNPY5RNPY1RCXCR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-11925667-B2	Engineered therapeutic probiotic system and method	CHANG MATTHEW WOOK (SG)	2024-03-12	—	—	US	disclosed